Retraction Note to: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8 (Targ Oncol, (2016), 11, (197-207), 10.1007/s11523-015-0390-9);MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8

Targeted Oncology

Volumn 11, Issue 2, 2016, Pages 197-207

  Wang, Ying ^a   Xu, Po ^a   Yao, Jun ^a   Yang, Ruina ^a   Shi, Zhenguo ^a   Zhu, Xiaojuan ^a   Feng, Xiaoshan ^a   Gao, Shegan ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 8; MESSENGER RNA; MICRORNA; MICRORNA 216B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER PROGNOSIS; CANCER STAGING; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EVENT FREE SURVIVAL; FLUORESCENCE ACTIVATED CELL SORTING; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; HDAC8 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; SURVIVAL PREDICTION; SURVIVAL TIME; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84944706857     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-016-0470-5     Document Type: Erratum

References (43)

1. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354–62
2. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M et al (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9(7):824–33
3. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S et al (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6(3):e1000879
4. Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19(9):1523–9
5. Ji Q, Hao X, Meng Y, Zhang M, DeSano J, Fan D et al (2008) Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8(1):266
6. Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12(2):192–8
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834–8
8. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34(suppl 1):D140–4
9. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39(5):673–7
10. Kota J, Chivukula RR, O’Donnell KA, Wentzel EA, Montgomery CL, Hwang H-W et al (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137(6):1005–17
11. He X, Chang Y, Meng F, Wang M, Xie Q, Tang F et al (2012) MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 31(28):3357–69
12. Cheng C-Y, Hwang C-I, Corney DC, Flesken-Nikitin A, Jiang L, Öner GM et al (2014) miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Reports 6(6):1000–7
13. Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C et al (2012) MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci 109(41):16570–5
14. Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J et al (2014) Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 33(2):193–202
15. Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D et al (2014) IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest 124(4):1853
16. Hossain A, Kuo MT, Saunders GF (2006) Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26(21):8191–201
17. Deng M, Liu J, Gu Y, Zheng G, He Z (2013) miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi 35(9):645–50
18. Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y et al (2011) miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci 124(17):2997–3005
19. Moser MA, Hagelkruys A, Seiser C (2014) Transcription and beyond: the role of mammalian class I lysine deacetylases. Chromosoma 123(1–2):67–78
20. Witt O, Deubzer HE, Milde T, Oehme I (2009) HDAC family: what are the cancer relevant targets? Cancer Lett 277(1):8–21
21. Oehme I, Deubzer HE, Wegener D, Pickert D, Linke J-P, Hero B et al (2009) Histone deacetylase 8 in neuroblastoma tumorigenesis. Clin Cancer Res 15(1):91–9
22. Wang Y, Zheng X, Zhang Z, Zhou J, Zhao G, Yang J et al (2012) MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of HDAC8 in human gastric cancer. PLoS One 7(10), e41693
23. Twentyman P, Luscombe M (1987) A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56(3):279
24. Van de Loosdrecht A, Beelen R, Ossenkoppele G, Broekhoven M, Langenhuijsen M (1994) A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 174(1):311–20
25. Xu X, Zhang Y, Zhang W, Li T, Gao H, Wang Y (2013) MicroRNA-133a functions as a tumor suppressor in gastric cancer. J Biol Regul Homeost Agents 28(4):615–24
26. Liang J, Liu X, Xue H, Qiu B, Wei B, Sun K (2015) MicroRNA‐103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c‐Myb. Cell Prolif 48(1):78–85
27. Shen X, Si Y, Yang Z, Wang Q, Yuan J, Zhang X (2015) MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. Med Oncol 32(1):1–8
28. Gu W, Gao T, Shen J, Sun Y, Zheng X, Wang J et al (2014) MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4. International Journal of Clinical and Experimental Medicine 7(9):2519
29. Zheng X, Dong J, Gong T, Zhang Z, Wang Y, Li Y et al (2015) MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation. J Cancer Res Clin Oncol 141(5):785–95
30. Li LP, Wu WJ, Sun DY, Xie ZY, Ma YC, Zhao YG (2014) miR-449a and CDK6 in gastric carcinoma. Oncology Letters 8(4):1533–8
31. Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J et al (2015) By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget 6(19):17559–69
32. Han X, Chen Y, Yao N, Liu H, Wang Z (2015) MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1. Cancer Gene Ther 22(3):122–9
33. Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381–95
34. Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10(1):32–42
35. Oehme I, Deubzer HE, Lodrini M, Milde T, Witt O (2009) Targeting of HDAC8 and investigational inhibitors in neuroblastoma. Expert Opin Investig Drugs 18(11):1605–17
36. Park SY, Jun J, Jeong KJ, Heo HJ, Sohn JS, Lee HY et al (2011) Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol Rep 25(6):1677–81
37. Abbas A, Gupta S (2008) The role of histone deacetylases in prostate cancer. Epigenetics 3(6):300–9
38. Lin CC, Papadopoulos K (2007) Novel targeted therapies for advanced esophageal cancer. Dis Esophagus 20(5):365–71
39. Nakagawa M, Oda Y, Eguchi T, Aishima S-I, Yao T, Hosoi F et al (2007) Expression profile of class I histone deacetylases in human cancer tissues. Oncol Rep 18(4):769–74
40. Hsieh T-H, Hsu C-Y, Tsai C-F, Long C-Y, Wu C-H, Wu D-C, et al (2015) HDAC inhibitors target HDAC5, upregulate MicroRNA-125a-5p, and induce apoptosis in breast cancer cells. Mol Ther 23(4):656–66
41. Chen D-Q, Huang J-Y, Feng B, Pan B-Z, De W, Wang R et al (2014) Histone deacetylase 1/Sp1/MicroRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma. PLoS One 9(10):e109578
42. Seol HS, Akiyama Y, Shimada S, Lee HJ, Im Kim T, Chun SM et al (2014) Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. Cancer Lett 353(2):232–41
43. Chen D-Q, Pan B-Z, Huang J-Y, Zhang K, Cui S-Y, De W et al (2014) HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells. Oncotarget 5(10):3333–49